Intercept Pharmaceuticals Overview
Intercept Pharmaceuticals Target Price
Analysts' 12-month price predictions for ICPT.
Get informed when a big investor buys or sells
+ FollowShare Price
$19
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2023-07-13 | H.C. WainwrightEd Arce | $19 |  0% upside |  |
| 2023-06-29 | Canaccord GenuityEdward Nash | $19 | 0% upside | |
| 2022-11-16 | H.C. Wainwright | $14 |  26.3% downside | |
| 2022-10-03 | Mizuho SecuritiesAnthony Crowdell | $27 | 42.1% upside | |
| 2021-11-04 | Raymond JamesSteven Seedhouse | $44 | 131.6% upside | |
| 2021-11-04 | BMO CapitalMatthew Luchini | $22 | 15.8% upside | |
| 2021-10-15 | JefferiesMichael Yee | $19 | 0% upside | |
| 2021-08-20 | Goldman SachsSalveen Richter | $10 | 47.4% downside | |
| 2021-05-07 | Cantor FitzgeraldAlethia Young | $23 | 21.1% upside | |
| 2021-05-06 | Wells FargoDerek Archila | $16 | 15.8% downside | |